Please assess the completion status of the following clinical trial:

Trial Title: Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Eisenmenger syndrome~* Negative pregnancy test~Exclusion Criteria:~* Elevated liver enzymes to more than 3´times normal value~* Hypotension (SBP \< 90 mmhg).~* Mandatory treatment with nitrates~* Myocardial infarction within 3 months~* Stroke within 3 months~* Known allergy to Bosentan or Sildenafil~* inherited degenerative diseases in retina~* Breast feeding~* Suspicion of risc of noncompliance.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).